{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:59:04Z","timestamp":1780621144749,"version":"3.54.1"},"reference-count":46,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The fetuses of pregnant women affected by anti-Ro\/anti-La antibodies are at risk of developing complete atrioventricular heart block (CAVB) and other potentially life-threatening cardiac affections. CAVB can develop in less than 24 h. Treatment with anti-inflammatory drugs and immunoglobulins (IVIG) can restore the normal rhythm if applied in the transition period. Routine weekly echocardiography, as often recommended, will rarely detect emergent AVB. The surveillance of these pregnancies is controversial. Home-monitoring using a hand-held Doppler is a promising new approach. Methods: To obtain an overview of the current practice in Germany, we developed a web-based survey sent by the DEGUM (German Society of Ultrasound in Medicine) to ultrasound specialists. With the intention to evaluate practicability of home-monitoring, we instructed at-risk pregnant women to use a hand-held Doppler in the vulnerable period between 18 and 26 weeks at our university center. Results: There are trends but no clear consensus on surveillance, prophylaxis, and treatment of anti-Ro\/La positive pregnant between specialists in Germany. Currently most experts do not offer home-monitoring but have a positive attitude towards its prospective use. Intensified fetal monitoring using a hand-held Doppler is feasible for pregnant women at risk and does not lead to frequent and unnecessary contact with the center. Conclusion: Evidence-based guidelines are needed to optimize the care of anti-Ro\/La-positive pregnant women. Individual risk stratification could help pregnancy care of women at risk and is welcmed by most experts. Hand-held doppler monitoring is accepted by patients and prenatal medicine specialists as an option for intensified monitoring and can be included in an algorithm for surveillance.<\/jats:p>","DOI":"10.3390\/jcm13041142","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T03:18:38Z","timestamp":1708312718000},"page":"1142","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Monitoring of Women with Anti-Ro\/SSA and Anti-La\/SSB Antibodies in Germany\u2014Status Quo and Intensified Monitoring Concepts"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7688-5357","authenticated-orcid":false,"given":"Ivonne Alexandra","family":"Bedei","sequence":"first","affiliation":[{"name":"Department of Prenatal Diagnosis and Fetal Therapy, Justus-Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kniess","sequence":"additional","affiliation":[{"name":"Department of Prenatal Diagnosis and Fetal Therapy, Philipps-University Marburg, 35041 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1455-1319","authenticated-orcid":false,"given":"Corinna","family":"Keil","sequence":"additional","affiliation":[{"name":"Department of Prenatal Diagnosis and Fetal Therapy, Philipps-University Marburg, 35041 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Wolter","sequence":"additional","affiliation":[{"name":"Department of Prenatal Diagnosis and Fetal Therapy, Justus-Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Schenk","sequence":"additional","affiliation":[{"name":"Department of Prenatal Diagnosis and Fetal Therapy, Justus-Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich J.","family":"Sachs","sequence":"additional","affiliation":[{"name":"Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig University, 35392 Giessen, Germany"},{"name":"Center for Transfusion Medicine and Hemotherapy, University Hospital Giessen and Marburg, 35041 Marburg, Germany"},{"name":"German Center for Fetomaternal Incompatibility (DZFI), University Hospital Giessen and Marburg, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Axt-Fliedner","sequence":"additional","affiliation":[{"name":"Department of Prenatal Diagnosis and Fetal Therapy, Justus-Liebig University Giessen, 35392 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/art.38458","article-title":"A42: Anti-Ro and Anti-La Antibodies in the General Pregnant Population: Rates and Fetal Outcomes","volume":"66","author":"Rozenblyum","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_2","unstructured":"Buyon, J.P., Saxena, A., Izmirly, P.M., Cuneo, B., and Wainwright, B. (2021). Systemic Lupus Erythematosus, Elsevier. Available online: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128145517000532."},{"key":"ref_3","unstructured":"Buyon, J.P., Saxena, A., and Izmirly, P.M. (2016). Systemic Lupus Erythematosus, Elsevier. Available online: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128019177000516."},{"key":"ref_4","unstructured":"Keogan, M., Kearns, G., and Jefferies, C.A. (2011). Systemic Lupus Erythematosus, Elsevier. Available online: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780123749949100154."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.20554","article-title":"Outcome of pregnancies in patients with anti-SSA\/Ro antibodies: A study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group","volume":"50","author":"Amoura","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained from a National Neonatal Lupus Registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","first-page":"69","article-title":"Anti-SSA\/Ro antibodies and the heart: More than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options","volume":"7","author":"Amoura","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: Development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/uog.26181","article-title":"Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to Anti-Ro\/SSA antibodies","volume":"62","author":"Keller","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/pd.5709","article-title":"A review of fetal and neonatal consequences of maternal systemic lupus erythematosus","volume":"40","author":"Limaye","year":"2020","journal-title":"Prenat. Diagn."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: A retrospective, multinational, multicenter study of 175 patients","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA\/Ro-Positive Mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Izmirly","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/jimmunol.1800357","article-title":"Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block","volume":"202","author":"Clancy","year":"2019","journal-title":"J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/BOR.0000000000000414","article-title":"Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus","volume":"29","author":"Izmirly","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-3083.2010.02439.x","article-title":"Role of calcium channels in congenital heart block","volume":"72","author":"Karnabi","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/jp.2016.220","article-title":"Heart sounds at home: Feasibility of an ambulatory fetal heart rhythm surveillance program for anti-SSA-positive pregnancies","volume":"37","author":"Cuneo","year":"2017","journal-title":"J. Perinatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Buyon, J.P., Masson, M., Izmirly, C.G., Phoon, C., Acherman, R., Sinkovskaya, E., Abuhamad, A., Makhoul, M., Satou, G., and Hogan, W. (2023). Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA\/Ro Pregnancies. Arthritis Rheumatol., 1\u201310.","DOI":"10.1002\/art.42733"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.jacc.2018.07.076","article-title":"Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies","volume":"72","author":"Cuneo","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/uog.24891","article-title":"Targeting neonatal Fc receptor: Potential clinical applications in pregnancy","volume":"60","author":"Moise","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/AOG.0b013e3181e75a4a","article-title":"Congenital fetal heart block: A potential therapeutic role for intravenous immunoglobulin","volume":"116","author":"David","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: Retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1191\/0961203302lu173oa","article-title":"Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA\/Ro-SSB\/La antibodies","volume":"11","author":"Askanase","year":"2002","journal-title":"Lupus"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.echo.2004.10.023","article-title":"Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies","volume":"18","author":"Raboisson","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/pd.5021","article-title":"Serial echocardiography for immune-mediated heart disease in the fetus: Results of a risk-based prospective surveillance strategy: Prevention strategy of cardiac neonatal lupus erythemathosus","volume":"37","author":"Kan","year":"2017","journal-title":"Prenat. Diagn."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.jacc.2018.08.1039","article-title":"Could Timing Be Everything for Antibody-Mediated Congenital Heart Block?","volume":"72","author":"Altman","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajog.2016.07.002","article-title":"Detection and successful treatment of emergent anti-SSA\u2013mediated fetal atrioventricular block","volume":"215","author":"Cuneo","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e023000","DOI":"10.1161\/JAHA.121.023000","article-title":"Outcome of Antibody-Mediated Fetal Heart Disease With Standardized Anti-Inflammatory Transplacental Treatment","volume":"11","author":"Mawad","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jacc.2010.12.014","article-title":"Prolongation of the Atrioventricular Conduction in Fetuses Exposed to Maternal Anti-Ro\/SSA and Anti-La\/SSB Antibodies Did Not Predict Progressive Heart Block","volume":"57","author":"Jaeggi","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/S2665-9913(19)30069-4","article-title":"Routine repeated echocardiographic monitoring of fetuses exposed to maternal anti-SSA antibodies: Time to question the dogma","volume":"1","author":"Morel","year":"2019","journal-title":"Lancet Rheumatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/uog.19277","article-title":"OC11.04: Fetal surveillance of anti-Ro\/anti-La affected pregnancies: Is there a consensus? Results of an international survey","volume":"52","author":"Carvalho","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_35","first-page":"36","article-title":"A review of congenital heart block","volume":"5","author":"Friedman","year":"2003","journal-title":"Images Paediatr. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The Importance of the Level of Maternal Anti-Ro\/SSA Antibodies as a Prognostic Marker of the Development of Cardiac Neonatal Lupus Erythematosus","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/art.42513","article-title":"Maternal Anti-Ro Antibody Titers Obtained with Commercially Available Immunoassays are Strongly Associated with Immune-Mediated Fetal Heart Disease","volume":"75","author":"Jaeggi","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/chd.12713","article-title":"Prenatal heart block screening in mothers with SSA\/SSB autoantibodies: Targeted screening protocol is a cost-effective strategy","volume":"14","author":"Evers","year":"2019","journal-title":"Congenit. Heart Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2016.09.119","article-title":"Fluorinated steroids do not improve outcome of isolated atrioventricular block","volume":"225","author":"Slieker","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.107.735118","article-title":"Perinatal outcome of fetal atrioventricular block: One-hundred-sixteen cases from a single institution","volume":"118","author":"Lopes","year":"2008","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block","volume":"62","author":"Amoura","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Michael, A., Radwan, A.A., Ali, A.K., Abd-Elkariem, A.Y., and Shazly, S.A. (2019). Use of antenatal fluorinated corticosteroids in management of congenital heart block: Systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. X, 4.","DOI":"10.1016\/j.eurox.2019.100072"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse Effects of Immunoglobulin Therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1055\/s-0037-1613331","article-title":"Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor","volume":"88","author":"Hansen","year":"2002","journal-title":"Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"644122","DOI":"10.3389\/fcvm.2021.644122","article-title":"Prenatal Management Strategy for Immune-Associated Congenital Heart Block in Fetuses","volume":"8","author":"Liao","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/rheumatology\/key141","article-title":"The prevention, screening and treatment of congenital heart block from neonatal lupus: A survey of provider practices","volume":"57","author":"Clowse","year":"2018","journal-title":"Rheumatology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/4\/1142\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:01:26Z","timestamp":1760104886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/4\/1142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,17]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13041142"],"URL":"https:\/\/doi.org\/10.3390\/jcm13041142","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,17]]}}}